Real-world events trump virtual gatherings
From virtual dance parties and raves to virtual happy hours and potlucks – online gatherings reached new heights during COVID-19, helping individuals stay connected during lockdowns. While it’s… read more.
From virtual dance parties and raves to virtual happy hours and potlucks – online gatherings reached new heights during COVID-19, helping individuals stay connected during lockdowns. While it’s… read more.
Weight loss via intermittent energy restriction (IER) results in changes in the brain and in the gut, according to scientists in China. IER involves days of relative fasting… read more.
An unprecedented resurgence in invasive meningococcal disease followed the lifting of pandemic restrictions in France, according to a paper published in the Journal of Infection and Public Health… read more.
Artery calcification is almost twice as common in people who stay up late, according to a study from the University of Gothenburg, Sweden. The scientists found that circadian function… read more.
For people with hearing loss, the risk of death is lower among those who regularly use a hearing aid, researchers reported on Jan. 3, 2024 in The Lancet… read more.
Your weekly digest of the top healthcare stories, covering news published from 01/01/2024 – 05/01/2024. The Daily Telegraph The rate of cancer diagnosis in Britain will reach one… read more.
Researchers from a Taiwanese study report that an increase in the risk of miscarriage is associated with benzodiazepine use during pregnancy, after adjustments for cofounders. The findings appeared… read more.
ASHP Midyear Clinical Meeting – Highlights Antimicrobial resistance (AMR) caused an estimated five million deaths in 2019 and by 2050 this is likely to rise to 10 million… read more.
Less than half of patients with malignant ureteral obstruction (MUO) – a serious complication of advanced cancer, with a poor prognosis – receive palliative care (PC) for their… read more.
A non-prescription drug abuse crisis in Japan seems only one overdose away. The demand for a particular anti-cough drug has been rising, along with the social impact of… read more.
Esperion announced that the FDA has approved an updated LDL-cholesterol lowering indication for Nexletol and Nexlizet to include the treatment of primary hyperlipidemia as a qualifier for existing… read more.
Octapharma USA announced the expansion of the FDA approval for wilate, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for Solution for Intravenous Injection. The approved label… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.